442 related articles for article (PubMed ID: 16642030)
1. Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.
Qian HS; Liu P; Huw LY; Orme A; Halks-Miller M; Hill SM; Jin F; Kretschmer P; Blasko E; Cashion L; Szymanski P; Vergona R; Harkins R; Yu J; Sessa WC; Dole WP; Rubanyi GM; Kauser K
Gene Ther; 2006 Sep; 13(18):1342-50. PubMed ID: 16642030
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent acceleration of ischemic injury in endothelial nitric oxide synthase-deficient mice: potential role of impaired VEGF receptor 2 expression.
Qian HS; de Resende MM; Beausejour C; Huw LY; Liu P; Rubanyi GM; Kauser K
J Cardiovasc Pharmacol; 2006 Apr; 47(4):587-93. PubMed ID: 16680073
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
5. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model.
Namba T; Koike H; Murakami K; Aoki M; Makino H; Hashiya N; Ogihara T; Kaneda Y; Kohno M; Morishita R
Circulation; 2003 Nov; 108(18):2250-7. PubMed ID: 14568906
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model.
Urano T; Ito Y; Akao M; Sawa T; Miyata K; Tabata M; Morisada T; Hato T; Yano M; Kadomatsu T; Yasunaga K; Shibata R; Murohara T; Akaike T; Tanihara H; Suda T; Oike Y
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):827-34. PubMed ID: 18258819
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium.
Kubo M; Egashira K; Inoue T; Koga J; Oda S; Chen L; Nakano K; Matoba T; Kawashima Y; Hara K; Tsujimoto H; Sueishi K; Tominaga R; Sunagawa K
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):796-801. PubMed ID: 19325146
[TBL] [Abstract][Full Text] [Related]
9. Passive exercise using whole-body periodic acceleration enhances blood supply to ischemic hindlimb.
Rokutanda T; Izumiya Y; Miura M; Fukuda S; Shimada K; Izumi Y; Nakamura Y; Araki S; Hanatani S; Matsubara J; Nakamura T; Kataoka K; Yasuda O; Kaikita K; Sugiyama S; Kim-Mitsuyama S; Yoshikawa J; Fujita M; Yoshiyama M; Ogawa H
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2872-80. PubMed ID: 21940947
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
[TBL] [Abstract][Full Text] [Related]
11. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
[TBL] [Abstract][Full Text] [Related]
12. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism.
Schgoer W; Theurl M; Jeschke J; Beer AG; Albrecht K; Gander R; Rong S; Vasiljevic D; Egger M; Wolf AM; Frauscher S; Koller B; Tancevski I; Patsch JR; Schratzberger P; Piza-Katzer H; Ritsch A; Bahlmann FH; Fischer-Colbrie R; Wolf D; Kirchmair R
Circ Res; 2009 Nov; 105(10):994-1002. PubMed ID: 19797703
[TBL] [Abstract][Full Text] [Related]
14. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice.
Qi X; Okamoto Y; Murakawa T; Wang F; Oyama O; Ohkawa R; Yoshioka K; Du W; Sugimoto N; Yatomi Y; Takuwa N; Takuwa Y
Eur J Pharmacol; 2010 May; 634(1-3):121-31. PubMed ID: 20206620
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
Nagahama R; Matoba T; Nakano K; Kim-Mitsuyama S; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2427-34. PubMed ID: 22879581
[TBL] [Abstract][Full Text] [Related]
17. Enhanced therapeutic angiogenesis by cotransfection of prostacyclin synthase gene or optimization of intramuscular injection of naked plasmid DNA.
Hiraoka K; Koike H; Yamamoto S; Tomita N; Yokoyama C; Tanabe T; Aikou T; Ogihara T; Kaneda Y; Morishita R
Circulation; 2003 Nov; 108(21):2689-96. PubMed ID: 14568901
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia.
Sugano M; Tsuchida K; Makino N
Circulation; 2004 Feb; 109(6):797-802. PubMed ID: 14970118
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study on treatment of acute limb ischemia with vascular endothelial growth factor-121 gene transfer].
Zheng ZH; Xu L; Fan XH
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2004 Mar; 18(2):142-5. PubMed ID: 15065417
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase--implications for gene therapy in cardiovascular diseases.
Dulak J; Józkowicz A; Guevara I; Dembińska-Kieć A
Pol J Pharmacol; 1999; 51(3):233-41. PubMed ID: 10600037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
